Search for Clinical Trial Results
AL Amyloidosis - 147 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease Condition:
Interventions: |
Not yet recruiting |
Study Name: A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis Condition: Amyloidosis Date: 2015-08-27 Interventions:
|
Terminated |
Study Name: Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis Condition: Primary Systemic Amyloidosis Date: 2002-02-14 Interventions:
|
Active, not recruiting |
Study Name: Study of Oral IXAZOMIB in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis Condition: Light-Chain Amyloidosis Date: 2011-03-15 Interventions: Drug: MLN9708 Patients will receive escalating doses of MLN9708 orally on Days 1, 8 and 15 of a 28-day c |
Completed |
Study Name: Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed Condition: Primary Systemic Amyloidosis Date: 2010-07-26 Interventions:
|
Completed |
Study Name: Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis Condition: Primary Systemic Amyloidosis Date: 2010-02-17 Interventions:
|
Completed |
Study Name: Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis Condition: Amyloidosis Date: 2013-11-15 Interventions:
|
Terminated |
Study Name: Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis Condition: Myeloma Date: 2013-03-06 Interventions:
|
Recruiting |
Study Name: A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early Condition:
Date: 2016-04-11 |
Completed |
Study Name: A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis Condition:
Date: 2009-04-28 Interventions:
|